This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Louisiana State University and Agricultural & Mechanical College, Melior Pharmaceuticals I, Inc.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Weina Cong: Innovator in Metabolic Health
Introduction
Weina Cong is a prominent inventor based in Exton, PA (US), known for her significant contributions to the field of metabolic health. With a focus on innovative treatments for various metabolic disorders, she has been awarded 3 patents that showcase her expertise and dedication to improving health outcomes.
Latest Patents
One of her latest patents involves the treatment of adipocytes, which provides compositions comprising a lyn kinase activator and TRPM8 agonist. This patent outlines methods for reducing blood glucose levels, weight gain, and fat depot levels. It also addresses the treatment of metabolic syndrome, obesity, prediabetes, type I and II diabetes, hypercholesterolemia, hypertension, and several other health conditions. The patent emphasizes the importance of inducing the beiging of adipocytes and preventing pancreatic beta cell degeneration, highlighting her innovative approach to tackling complex health issues.
Career Highlights
Weina Cong has worked with notable organizations such as Melior Pharmaceuticals Inc. and Louisiana State University and Agricultural & Mechanical College. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Andrew G. Reaume and Frank L. Greenway, who have played a significant role in her research endeavors.
Conclusion
Weina Cong's innovative work in metabolic health and her impressive portfolio of patents reflect her commitment to advancing medical science. Her contributions are paving the way for new treatments that can significantly improve the quality of life for individuals with metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile